Avid Bioservices Inc (CDMO)

[freethemice]

Asian patients, as in Japanese and Chinese, do live longer. But, these were from India, AND you can see on the
subgroup analysis table that the Asian subgroup had a higher HR number (closer to 1) than the European and
United States patients. If the Asian patients were a factor then their HR number would be smaller, not larger.
In other words, bavi + docetaxel was of more benefit to the US and European patients than to the Asian patients,
contrary to your claim.
Sorry, I posted this by mistake on the Biotech Values board in response to
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88598114
I won't do that again!